financetom
Business
financetom
/
Business
/
Maze Therapeutics Appoints Herve Hoppenot as Board Chairman
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Maze Therapeutics Appoints Herve Hoppenot as Board Chairman
Oct 6, 2025 5:21 AM

07:55 AM EDT, 10/06/2025 (MT Newswires) -- Maze Therapeutics ( MAZE ) said Monday it appointed Herve Hoppenot as its board chairman.

Hoppenot succeeds Charles Homcy, who will continue to serve on Maze's board, the company said.

Hoppenot most recently served as chairman and CEO of biopharmaceutical firm Incyte ( INCY ) , according to a statement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved